Search

Your search keyword '"Bruzek, Amy"' showing total 4 results
Start Over Author "Bruzek, Amy" Language undetermined
4 results on '"Bruzek, Amy"'

1. Additional file 2: of CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

Author

Stallard, Stefanie, Savelieff, Masha, Wierzbicki, Kyle, Mullan, Brendan, Miklja, Zachary, Bruzek, Amy, Garcia, Taylor, Siada, Ruby, Anderson, Bailey, Singer, Benjamin, Rintaro Hashizume, Carcaboso, Angel, McMurray, Kaitlin, Heth, Jason, Muraszko, Karin, Robertson, Patricia, Rajen Mody, Sriram Venneti, Garton, Hugh, and Koschmann, Carl

Subjects
3. Good health
Abstract

Figure S1. Serial dilution of K27M mutant oligonucleotide in constant background of wild-type DNA demonstrates consistent detection down to at least 2% VAF under typical experimental conditions, with the possibility of detection at even lower VAF under ideal conditions. One such dilution series is shown above, with (a) showing number of droplets positive for mutant or wild-type H3F3A sequence and (b) showing the corresponding VAF values. Figure S2. Plot of droplets (blue â positive mutant H3F3A K27M, green â positive wildtype H3F3A, grey â negative droplets) from ddPCR performed on (a) non-tumor human CSF spiked with synthetic K27M mutant sequence oligonucleotide and (b) non-tumor human CSF alone. (DOCX 268 kb)

2. Additional file 1: of CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

Author

Stallard, Stefanie, Savelieff, Masha, Wierzbicki, Kyle, Mullan, Brendan, Miklja, Zachary, Bruzek, Amy, Garcia, Taylor, Siada, Ruby, Anderson, Bailey, Singer, Benjamin, Rintaro Hashizume, Carcaboso, Angel, McMurray, Kaitlin, Heth, Jason, Muraszko, Karin, Robertson, Patricia, Rajen Mody, Sriram Venneti, Garton, Hugh, and Koschmann, Carl

Subjects
3. Good health
Abstract

Supplemental Information. Detailed methods and H3F3A K27M assay design. (DOCX 28 kb)

3. Additional file 1: of CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

Author

Stallard, Stefanie, Savelieff, Masha, Wierzbicki, Kyle, Mullan, Brendan, Miklja, Zachary, Bruzek, Amy, Garcia, Taylor, Siada, Ruby, Anderson, Bailey, Singer, Benjamin, Rintaro Hashizume, Carcaboso, Angel, McMurray, Kaitlin, Heth, Jason, Muraszko, Karin, Robertson, Patricia, Rajen Mody, Sriram Venneti, Garton, Hugh, and Koschmann, Carl

Subjects
3. Good health
Abstract

Supplemental Information. Detailed methods and H3F3A K27M assay design. (DOCX 28 kb)

4. Additional file 2: of CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

Author

Stallard, Stefanie, Savelieff, Masha, Wierzbicki, Kyle, Mullan, Brendan, Miklja, Zachary, Bruzek, Amy, Garcia, Taylor, Siada, Ruby, Anderson, Bailey, Singer, Benjamin, Rintaro Hashizume, Carcaboso, Angel, McMurray, Kaitlin, Heth, Jason, Muraszko, Karin, Robertson, Patricia, Rajen Mody, Sriram Venneti, Garton, Hugh, and Koschmann, Carl

Subjects
3. Good health
Abstract

Figure S1. Serial dilution of K27M mutant oligonucleotide in constant background of wild-type DNA demonstrates consistent detection down to at least 2% VAF under typical experimental conditions, with the possibility of detection at even lower VAF under ideal conditions. One such dilution series is shown above, with (a) showing number of droplets positive for mutant or wild-type H3F3A sequence and (b) showing the corresponding VAF values. Figure S2. Plot of droplets (blue â positive mutant H3F3A K27M, green â positive wildtype H3F3A, grey â negative droplets) from ddPCR performed on (a) non-tumor human CSF spiked with synthetic K27M mutant sequence oligonucleotide and (b) non-tumor human CSF alone. (DOCX 268 kb)

Catalog

Books, media, physical & digital resources
See catalog results